UPDATE | August 25, 2026

Enhancing AAV manufacturing yield through a promoter optimized mini helper plasmid

  • MAIL

AAV manufacturing efficiency can be improved through optimized plasmid design and transfection strategies that reduce plasmid DNA input while supporting higher AAV titers.


In this on-demand webinar, Kihyun Park, Ph.D., Lead Scientist in AAV Process Discovery at Samsung Biologics, discusses how a promoter-optimized mini-helper plasmid can improve AAV titers with reduced plasmid DNA input while maintaining particle quality across scales.


Key highlights include:

  • The design strategy behind the promoter-optimized mini-helper plasmid and how its compact structure can reduce DNA synthesis costs while retaining essential adenoviral helper functions

  • How optimized transfection conditions using the mini-helper platform can significantly improve AAV titers while reducing total plasmid DNA input

  • How the mini-helper platform can support next-generation AAV manufacturing strategies, including stable cell line development and dual-vector applications


Discover how innovative plasmid design and process optimization can help advance more efficient and scalable AAV manufacturing.


AAV manufacturing efficiency can be improved through optimized plasmid design and transfection strategies that reduce plasmid DNA input while supporting higher AAV titers.


In this on-demand webinar, Kihyun Park, Ph.D., Lead Scientist in AAV Process Discovery at Samsung Biologics, discusses how a promoter-optimized mini-helper plasmid can improve AAV titers with reduced plasmid DNA input while maintaining particle quality across scales.


Key highlights include:

  • The design strategy behind the promoter-optimized mini-helper plasmid and how its compact structure can reduce DNA synthesis costs while retaining essential adenoviral helper functions
  • How optimized transfection conditions using the mini-helper platform can significantly improve AAV titers while reducing total plasmid DNA input
  • How the mini-helper platform can support next-generation AAV manufacturing strategies, including stable cell line development and dual-vector applications


Discover how innovative plasmid design and process optimization can help advance more efficient and scalable AAV manufacturing.


Share article

Related Content

SITE MAP

close
Close

Your download is ready

Click Download.

Close

Subscribe to Our Newsletter

Please fill in your details, select one or more areas of interest, and click the subscribe button to receive our newsletter.

Subscribe to Our Newsletter
  • Interests
  • Privacy Policy to collect the email address that I have provided until I withdraw my consent. The collected information will only be used for the purpose of mailing service. If you do not wish to consent, you will not be able to receive the newsletter. Samsung Biologics respects the privacy of its subscribers.
Close

Please fill out the form
to view the full content

Please sign up to view the post..
* Required
Privacy Policy required